45 search results for: biologics

<b>Biologics</b> in CRSwNP: Comparative Efficacy and Real-World Effectiveness
expert video

Biologics in CRSwNP: Comparative Efficacy and Real-World Effectiveness

Rhinology
Professor Eugenio De Corso discusses indirect comparisons of biologics approved for patients with uncontrolled CRSwNP and emerging real-world effectiveness of biologics for patients with CRSwNP.
View more
How Can <b>Biologics</b> Improve Lung Function in Pediatric Severe Asthma?
expert video

How Can Biologics Improve Lung Function in Pediatric Severe Asthma?

Pulmonology
Dr. Leonard Bacharier discusses the role of biologics in the improvement of lung function in pediatric severe asthma
View more
Comparative Efficacy of <b>Biologics</b> for Patients with Uncontrolled and/or Severe CRSwNP
expert video

Comparative Efficacy of Biologics for Patients with Uncontrolled and/or Severe CRSwNP

Rhinology
Prof. Peter Hellings presents the comparative efficacy of biologics for patients with uncontrolled and/or severe CRSwNP.
View more
EAACI 2023 | <b>Biologics</b> in CRSwNP: Comparative Efficacy and Real-World Effectiveness
expert video

EAACI 2023 | Biologics in CRSwNP: Comparative Efficacy and Real-World Effectiveness

Rhinology
Join Profs. Martin Wagenmann and Eugenio De Corso as they discuss type 2 inflammation in CRSwNP and explore real-world data on biologic efficacy.
View more
ERS 2024 | Can <b>Biologics</b> Affect Airway Remodeling?
expert video

ERS 2024 | Can Biologics Affect Airway Remodeling?

Pulmonology
Dr Mario Castro presents the latest clinical data on biologics showcasing their effect on airway remodeling parameters and airway hyperresponsiveness in patients with severe asthma.
View more
What proportion of patients can achieve control in CRSwNP?
expert video

What proportion of patients can achieve control in CRSwNP?

Rhinology
Join Prof. Hellings and Prof. Corso in dicussion on the factors affecting complete control of CRSwNP, including treatment types, comorbidities, and the need for more data on biologics.
View more
ERS 2024 | How Can <b>Biologics</b> Help Achieve Clinical Remission in Children With Severe Asthma?
expert video

ERS 2024 | How Can Biologics Help Achieve Clinical Remission in Children With Severe Asthma?

Pulmonology
In this ADVENT symposium at the 2024 European Respiratory Society conference, Dr. Sharon Dell highlights the available clinical biologic efficacy data in pediatric severe asthma, suggesting the potential for achieving clinical remission when added to an asthma management plan.
View more
Evaluating the Responses to Biologic Therapies in Children With Atopic Dermatitis
expert video

Evaluating the Responses to Biologic Therapies in Children With Atopic Dermatitis

Dermatology
Dr. Amy Paller shares her opinion on practical considerations for evaluating response during treatment with biologics in children with atopic dermatitis.
View more
ERS 2023 | How Achievable Is Clinical Remission on Biologic Therapy?
expert video

ERS 2023 | How Achievable Is Clinical Remission on Biologic Therapy?

Pulmonology
Dr. Francesca Puggioni presents the latest clinical data on achieving on-treatment remission with biologics.
View more
ERS 2024 | Perspectives From the Evolving Biologic Landscape in COPD
expert video

ERS 2024 | Perspectives From the Evolving Biologic Landscape in COPD

Pulmonology
Professor Alberto Papi presents the latest clinical data on current and emerging biologics for COPD with type 2 inflammation.
View more
Targeting Underlying Inflammation in CRSwNP, a Type 2 Inflammatory Disease
expert video

Targeting Underlying Inflammation in CRSwNP, a Type 2 Inflammatory Disease

Rhinology
Professor Martin Wagenmann describes the mechanisms through which type 2 inflammation drives symptoms in patients with CRSwNP.
View more
Should we Still Operate on Patients With Chronic Rhinosinusitis With Nasal Polyps?
expert video

Should we Still Operate on Patients With Chronic Rhinosinusitis With Nasal Polyps?

Rhinology
This video clip from the EAACI 2024 symposium discusses whether patients with CRSwNP should undergo a surgery.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: IsraelChange country/region